HB 3001

  • Illinois House Bill
  • 104th Regular Session
  • Introduced in House
  • House
  • Senate
  • Governor

Ins Cd-Cancer Screenings

Abstract

Amends the Illinois Insurance Code. In a provision concerning coverage of certain cancer screenings, adds having a high level of CA-125, as indicated by a blood test screening, to the definition of "at risk for ovarian cancer". Provides that "surveillance tests for ovarian cancer" means all medically viable methods for the detection and diagnosis of ovarian cancer, including, but not limited to, ultrasounds, magnetic resonance imagings (MRIs), x-rays, computed tomography (CT) scans, and CA-125 blood test screenings (instead of an annual screening using (i) CA-125 serum tumor marker testing, (ii) transvaginal ultrasound, (iii) pelvic examination). Effective January 1, 2027.

Bill Sponsors (2)

Votes


No votes to display

Actions


Dec 05, 2025

House

Added Co-Sponsor Rep. Amy Briel

Mar 21, 2025

House

Rule 19(a) / Re-referred to Rules Committee

Mar 12, 2025

House

To Insurance Main Subcommittee

Mar 04, 2025

House

Assigned to Insurance Committee

Feb 06, 2025

House

Filed with the Clerk by Rep. Norine K. Hammond

House

First Reading

House

Referred to Rules Committee

Bill Text

Bill Text Versions Format
Introduced HTML PDF

Related Documents

Document Format
No related documents.

Sources

Data on Open States is updated periodically throughout the day from the official website of the Illinois General Assembly.

If you notice any inconsistencies with these official sources, feel free to file an issue.